In April 2016 the Judicial Panel on Multidistrict Litigation created a multi-district litigation (MDL) court for lawsuits against Pfizer, the maker of Viagra. That MDL is No. 2691. Plaintiffs in those cases allege that taking Viagra increased the risk of developing melanoma, a potentially deadly skin cancer. MDLs are created when many lawsuits are filed alleging very similar facts against the same defendants for similar injuries. One consolidated court permits a more efficient pre-trial process, where discovery can be organized, consolidated, and “shared” among all parties. Now men who allege they developed melanoma from taking Cialis have asked to join the Viagra MDL.
The Motion
On September 28, 2016, several plaintiffs who have filed suit against Eli Lilly and Co., the maker of Cialis (another erectile dysfunction drug), asked the judge presiding over the Viagra MDL to permit all plaintiffs suing Eli Lilly to transfer their cases to MDL 2691. The plaintiffs alleging injury from Cialis argue that the science behind the Cialis cases is essentially the same as the science behind the cases involving Viagra. According to the motion, the Cialis Plaintiffs allege that their injuries “were caused by Cialis through the exact same mechanism of action.”